Krystal Biotech to File IND Application for KB103 to Treat Dystrophic Epidermolysis Bullosa – Epidermolysis Bullosa News
Epidermolysis Bullosa NewsKrystal Biotech to File IND Application for KB103 to Treat Dystrophic Epidermolysis BullosaEpidermolysis Bullosa NewsDystrophic epidermolysis bullosa is an inherited disease characterized by defective production of collagen fi… Continue reading
